RxCelerate
  • Home
  • About
    • About RxCelerate
    • Leadership
    • Company Values
    • Client Testimonials
    • Careers
  • Services
    • In Silico
    • Antibody Discovery
    • Chemistry
    • Biology
      • In Vitro
      • Drosophila
      • Preclinical
      • Histology
    • Proteomics
      • Services
      • ProQuant
      • Case Studies
    • Experimental Medicine
    • Project Management
  • News
  • Resources
    • Case Studies
    • Posters
    • Events
  • Contact
Select Page
Leading UK drug developer RxCelerate opens first US base in Boston

Leading UK drug developer RxCelerate opens first US base in Boston

by admin | Nov 8, 2017 | Media

Leading UK drug developer RxCelerate opens first US base in Boston RxCelerate, one of the leading out-sourced drug discovery and development platforms in the United Kingdom, announced today it has hired Laura Hamilton as Executive Vice President, US Operations and...
Next Entries »

A leading drug discovery and development platform based in Cambridge (UK) delivering integrated programmes to our clients.

Get in touch

Call Us 01223 839557
Email Us [email protected]

Visit Us

The Dorothy Hodgkin Building, 
Babraham Research Campus,
Babraham, Cambridge CB22 3FH

Copyright © 2025 RxCelerate ¤ View our Privacy Policy ¤ Designed & Developed by Identity Creative

    Join our Mailing List
    To receive the latest news and updates from RxCelerate, join our mailing list using the form below.

    Marketing Permissions
    Please select how you would like to hear from RxCelerate:

    You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please read our privacy policy.

    We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.